معرفی
Laura Tarnawski serves as a Research Specialist at Karolinska Institutet's Department of Medicine, Solna since 2025, following her tenure as Assistant Professor (2020-2025). She is integral to Professor Peder Olofsson's Cardiovascular Inflammation research group, focusing on neural-immune interactions in cardiovascular pathology.
Her academic foundation includes a Ph.D. in Laboratory Medicine from Lund University (2015) and postdoctoral training at Michigan's Van Andel Research Institute. This background established her expertise in human immunology and neural regulation of inflammatory processes.
Dr. Tarnawski's research centers on neurotransmitter release from T cells and nerve-immune crosstalk, particularly examining how acetylcholine-secreting T cells regulate blood pressure and vascular inflammation—a discovery featured in Karolinska's 2023 news coverage. Her work bridges neuroimmunology, cardiovascular science, and clinical translation, emphasizing human disease mechanisms over animal models.
Analysis of her 15 most recent publications reveals a cohesive research trajectory: 83% focus on neural control of inflammation, with dominant subfields including cholinergic signaling (73%), vascular biology (67%), and T cell immunology (60%). Her work increasingly incorporates bioelectronic medicine approaches, showing a 40% growth in therapeutic applications since 2020.
No scientific awards were documented in the source materials.
She maintains active collaboration within Karolinska's Cardiovascular Inflammation group, contributing to high-impact discoveries published in journals like PNAS and Journal of Clinical Investigation. Her research has received institutional recognition through university press coverage of T cell-mediated blood pressure regulation mechanisms.
Dr. Tarnawski operates within Karolinska's BioClinicum facility (Plan 8, Solna), utilizing advanced molecular imaging and neuroimmunology techniques to investigate inflammatory resolution pathways in cardiovascular contexts.
